Multimodal Biomarkers for Diagnosis and Prognosis in CAA

Clinical trial NCT03969732 · UNKNOWN

Trial details

NCT number: NCT03969732
Sponsor: National Taiwan University Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Cerebral Amyloid Angiopathy Intracranial Hemorrhages Alzheimer Disease

Start date: 2018-09-27
Primary completion: 2022-07-31
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.